Page last updated: 2024-09-04

cryptotanshinone and Bile Duct Cancer

cryptotanshinone has been researched along with Bile Duct Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gong, W; Hu, Y; Jiang, L; Ke, F; Liu, Y; Ma, Q; Song, X; Wang, Z; Zhang, Y	1

Other Studies

1 other study(ies) available for cryptotanshinone and Bile Duct Cancer

Article	Year
Cryptotanshinone induces cell cycle arrest and apoptosis through the JAK2/STAT3 and PI3K/Akt/NFκB pathways in cholangiocarcinoma cells. Drug design, development and therapy, 2017, Volume: 11 Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Bile Duct Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cholangiocarcinoma; Humans; Janus Kinase 2; Male; Mice; Mice, Nude; NF-kappa B; Oncogene Protein v-akt; Phenanthrenes; Phosphatidylinositol 3-Kinases; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays	2017

Article

Year

Cryptotanshinone induces cell cycle arrest and apoptosis through the JAK2/STAT3 and PI3K/Akt/NFκB pathways in cholangiocarcinoma cells.

Drug design, development and therapy, 2017, Volume: 11

Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Bile Duct Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cholangiocarcinoma; Humans; Janus Kinase 2; Male; Mice; Mice, Nude; NF-kappa B; Oncogene Protein v-akt; Phenanthrenes; Phosphatidylinositol 3-Kinases; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays

2017